Haymaker Target Arko Buying $100M of Additional Convenience Stores

ARKO | Haymaker Merger II

The SPAC said merger partner Arko Holdings plans to acquire approximately 60 self-operated sites in midwestern states for 100 million plus the value of inventory and cash in stores. Read more.

Total
0
Shares
Related Posts
Read More

HDL Therapeutics Combining with Swiftmerge Acquisition in $480M Deal

The target is a commercial stage biotech company with an FDA-approved cardiovascular therapy the Plasma Delipidation System (PDS-2™ System) for reducing coronary atheroma in patients with homozygous familial hypercholesterolemia. Cholesterol and calcium deposits are the common culprits behind this arterial condition.